^
TNFRSF8 expression
Peripheral T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
belinostat
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
pralatrexate
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
denileukin diftitox
Sensitive
:
A1
ALK positive
Peripheral T-cell Lymphoma
crizotinib
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
etoposide IV
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
cyclophosphamide
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
cyclophosphamide + etoposide IV
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
bortezomib
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
bendamustine
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
alemtuzumab
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
lenalidomide
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
gemcitabine
Sensitive
:
A2
TNFRSF8 positive
Peripheral T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
EPOCH
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
duvelisib
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
DHAX
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
DHAP
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
cyclosporine
Sensitive
:
A2
ALK positive
Peripheral T-cell Lymphoma
alectinib
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
romidepsin
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
ICE
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
GemOx
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
GDP
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
GVD
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
ESHAP
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
RP6530
Sensitive
:
B
No biomarker
Peripheral T-cell Lymphoma
DZD4205
Sensitive
:
B
IL2RA expression
Peripheral T-cell Lymphoma
denileukin diftitox
Sensitive
:
C1
PD-L1 overexpression
Peripheral T-cell Lymphoma
GB226
Sensitive
:
C3
PD-1 overexpression
Peripheral T-cell Lymphoma
nivolumab
Sensitive
:
C3